DLA Piper managing partner Emilio Ragosa is joined by Kevin Sheridan, Joint Global Head of Healthcare Investment Banking at Jefferies LLC, to discuss the importance of advisors having an understanding of the life sciences industry in order to provide value-added advice on transactions, including public offerings and M&A.

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
29:37

Life sciences companies and the risks posed by the mifepristone litigation
33:17

Trade secrets protection in the life sciences sector
21:22